X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Mithra Receives GMP approval for Myring production

Yuvraj_pawp by Yuvraj_pawp
23rd May 2017
in Manufacturing

Mithra , a company specialized in Women’s Health, is pleased to announce that the Mithra CDMO1 has received Good Manufacturing Practice (GMP) approval for the production line of Myring , a combined hormonal contraceptive vaginal ring

made of ethylene vinyl acetate copolymers (EVA).

Following the GMP approval by AFMPS, the Belgian Federal Agency for Medicines and Health Products,Mithra will be able to ship its first commercial batches in the European Union once marketing approval has been received. The Company is on track to file for marketing approval in both Europe and the United States in Q2 2017.

Myring’sTM originator product, NuvaringTM, will go off patent in April 2018, allowing other products,such as MyringTM, to enter the US and European market. The vaginal ring market in Europe and the US is valued at EUR 143m and EUR 740m2
respectively.

Mithra recently announced a 10-year license and supply agreement with Gynial GmbH, for the commercialization of MyringTM in Austria. This followed news in February of an exclusive long-term license and supply agreement with Mayne Pharma, a leading specialty pharmaceutical company, for the commercialization of MyringTM in the US.

François Fornieri, CEO of Mithra, commented: “GMP approval of our manufacturing line is an important milestone for our vaginal contraceptive MyringTM as well as for Mithra’s manufacturing and development capabilities at our dedicated CDMO. We already have an excellent partnership in the US with Mayne Pharma and recently announced a further licensing agreement for MyringTM in Austria.

Today’s GMP accreditation will further assist ongoing discussions with potential licensing and distribution partners in Europe and other key markets.”

For more information, please contact:
Press
Julie Dessart
Chief Communication Officer
+32 4 349 28 22 / +32 475 86 41 75
press@mithra.com


1 Contract Development & Manufacturing Organization

2 Based on IMS Analytics 2016


Investor Relations

François Fornieri, CEO
+32 4 349 28 22
investorrelations@mithra.com

Sofie Van Gijsel, IRO

+32 485 19 14 15
svangijsel@mithra.com

Consilium Strategic Communications

Jonathan Birt, Sue Stuart, Hendrik Thys, Cameron Standage
mithra@consilium-comms.com
+44 2 037 095 700

About Mithra

Mithra is dedicated to providing innovation and choice in women’s health, with a particular focus on fertility, contraception and menopause. Mithra’s goal is to develop new and improved products that meet women’s needs for better safety and convenience. Its two lead development candidates – a fifth generation oral contraceptive Estelle® and next-generation hormone therapy Donesta® – are built on Mithra’s unique natural estrogen platform, E4 (Estetrol). Mithra also develops, manufactures and markets complex therapeutics and offers partners a complete spectrum of research, development and specialist manufacturing at its Mithra CDMO. Mithra was founded in 1999 as a spin-off of the University of Liège by Mr. François Fornieri and Prof. Dr. Jean-Michel Foidart.

Mithra is headquartered in Liège, Belgium. Further information can be found at: www.mithra.com

Previous Post

GE Healthcare’s FlexFactory to power Dr. Reddy’s biosimilar expansion plans

Next Post

Nutra Pharma and University of Maryland Bioprocess Scale-Up Facility for Phase II Studies

Related Posts

Manufacturing

OSD Contract Manufacturing Sector Valued At $54.7bn By 2030

10th October 2022
Biden Aims To Boost US Biomanufacturing Under Chinese Threat
Manufacturing

Biden Aims To Boost US Biomanufacturing Under Chinese Threat

16th September 2022
Empowering the healthcare fraternity through dynamic online courses
Manufacturing

Empowering the healthcare fraternity through dynamic online courses

9th September 2022
CRISPR Could Overcome Gene And Cell Therapy Limitations
Drug Development

CRISPR Could Overcome Gene And Cell Therapy Limitations

29th August 2022
Moderna Announces the EC's Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19
Drug Development

Moderna Sues Pfizer, BioNTech For mRNA COVID-19 Vaccinations

29th August 2022
Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022
Manufacturing

Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022

27th August 2022
Next Post

Nutra Pharma and University of Maryland Bioprocess Scale-Up Facility for Phase II Studies

Latest News

Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In